MINE SAFETY APPLIANCES CO. (MSA - $63.27) Q3 Better Than Expected BUY Aggressive

Size: px
Start display at page:

Download "MINE SAFETY APPLIANCES CO. (MSA - $63.27) Q3 Better Than Expected BUY Aggressive"

Transcription

1 Richard A. Ryan (612) Safety Equipment Manufacturer November 6, 2003 Financial Summary Rev E 2004E (mil) March $128.1 $160.4A $175.1E June $141.9 $176.4A $192.0E Sept. $143.4 $173.5A $187.7E Dec. $151.1 $172.3E $188.0E FY $564.4 $683.0E $742.8E EPS E 2004E March $0.63 $0.86A $0.94E June $0.64 $0.99A $1.04E Sept. $0.43 $0.88A $0.94E Dec. $0.83 $0.89E $0.98E FY $2.54 $ 3.62E $3.90E P/E 24.9x 17.5x 16.2x P/Sales 1.4x 1.2x 1.1x 52-Week Range: $ Price Target: $75.00 Shares Outstanding: 12.5 mil Mkt. Capitalization: $790.9 mil Ave. Volume: 14,363 Inst. Ownership: 37% BV / Share $27.30 Div./Yield $0.80/1.3% Debt / Tot. Cap.: 18% Est. LT EPS Growth: 10%-12% Company Description MSA is primarily engaged in the manufacture and sale of products designed to protect the safety and health of people throughout the world. MINE SAFETY APPLIANCES CO. (MSA - $63.27) Q3 Better Than Expected BUY Aggressive Highlights: Q3 and special dividend both above expectations. Momentum should continue into Q4 and Action: Increasing estimates (slightly) for Q4 and for 2004 (see attached table). Increasing price target to $ MSA reported a much stronger Q3 than we expected. The markets primarily responsible to the out performance continue to be related to homeland security and the fire service. International efforts, outside of Europe, have shown good progress and should continue as the global economy picks up steam. Europe remains sluggish, but this market should show better results in the second half of 2004 and beyond. MSA announced it will pay out $53.9 million, the proceeds from the sale of its chemical division, to shareholders. The per share amount will be $4.38 and will be for holders of record on 11/14, with distribution on 11/24. This dividend is higher than anticipated, but reflects the cash flow generating ability of MSA. In Q3, cash flow from operations was about $24 million. MSA has a long operating history, and has established an impressive reputation of providing safety products globally. MSA has introduced a self-contained breathing apparatus approved under both the new U.S. Chemical Biological Radiological Nuclear (CBRN) Standard and the latest National Fire Protection Association (NFPA) Standard. Only MSA and Tyco have achieved such approval, which could be a critical advantage if, and when, the government requires such chemical and biological capabilities. The Department of Homeland Security has released $2.2 billion in grants to states and municipalities for first responder funding. Since March, DHS has allocated or awarded more than $6.0 billion in grants to first responders. We believe MSA is in an ideal position to benefit from this additional funding. MSA is conservatively managed. The pension plan is over-funded, and management definitely has skin in the game. There is a guideline for management s stock ownership dependent on salary levels. This commitment is beyond having their salary, bonus, benefits and pensions tied to the future of MSA. There is a hidden asset to the MSA story. MSA owned over 300 acres of land in a fast-growing northern suburb of Pittsburgh. It has built two of its own facilities on the property and is in the midst of developing the rest of the office park. Three office buildings have been put up and Hilton just opened a hotel on the property. We believe there is still around 200 acres left with potential land values of between $150K-$400K (per acre). This asset is on the books for less than $500K. Management has not provided guidance and we do not believe they will change this practice. Up to this point MSA has not held conference calls, but we do believe they will start this practice. Also, management has started a more pro-active investor relations campaign that includes non-banking institutional visits. Investment Recommendation/Valuation Method For Setting Price Target Our $75 price target is based on 19.2x our 2004 EPS estimate and 2.7x MSA s book value of $ At this level. MSA would be trading at 1.4x our 2004 sales estimate and at 9.0x EV/EBITDA. This target price doesn t include the approximate $5.00 per share that exists from the underlying real estate assets not reflected in the current book value. We reiterate our Buy rating for aggressive investment accounts. Feltl and Company Research Department. 120 South Sixth Street, Suite 2600 Minneapolis, MN Please see important disclosures at end of report.

2 INVESTMENT CONCLUSION Increasing funds for domestic First Responders, a growing base of retail business and the use of safety equipment internationally combine to create significant growth opportunities for MSA. Sales into the First Reponder channel and growing international safety concerns are apparent, but we expect the retail channel to be a more meaningful contributor. Currently, MSA provides products to about one-half of Home Depot stores. There are no pure-play comparables to consider when valuing MSA. The multibillion market is highly fragmented globally. MSA has established a dominant industry position, operates in a modest growth industry and generates generous cash flow for internal growth and strategic acquisitions. Industries with similar characteristics include office products retailers and select medical products companies and value-added distributors. Valuations for each of these sectors surpasses the current valuation of MSA by a wide margin. On a P/E basis, valuations for 2004 can range between 17x-30x (or more). Based on book value, multiples can range from 2.5x-6.0x. Our $75 price target is based on 19.2x our 2004 EPS estimate and 2.7x MSA s book value of $ At this level, MSA would be trading at 1.4x our 2004 sales estimate and at 9.0x EV/EBITDA. This target price doesn t include the approximate $5.00 per share that exists from the underlying real estate assets not reflected in the current book value. We are maintaining our Buy rating for aggressive investment accounts. COMPANY DESCRIPTION Headquartered in Pittsburgh, PA and incorporated in 1914, Mine Safety Appliances Company is the largest company dedicated to producing a complete range of equipment and systems for firefighters, homeland security, military, industrial workers and plant protection. MSA s operations extend globally through 28 international affiliates serving over 140 countries. Key offerings include respiratory protective equipment including gas masks and self-contained breathing apparatus, products for head, eye and face protection, hearing protection products, thermal imaging cameras, fall protection equipment, and portable and permanently installed gas detection and monitoring devices. MSA's Safety Products Division develops, manufactures and markets personal protective products such as respirators, self-contained breathing apparatus, hard hats, clothing, hearing protectors, eye and face protectors, and thousands of products used in industries worldwide. The company's Instrument Division does the same with thermal imaging cameras and sophisticated portable and continuous instruments to monitor workplace environments for toxic and combustible gases. Page2 Mine Safety Appliances Company (MSA) 11/6/03

3 THIRD QUARTER RESULTS REVENUE: Total sales were $171.9 million compared with $143.4 million in the year ago quarter, representing of gain of 19.9%. Other income in the quarter was $1.6 million compared to a loss of $232K a year ago. Strong demand for breathing apparatus products to the fire service market and gas masks for the U.S. military contributed to the strong sales increase. For the nine months, net sales were $508.3 million compared to $413.3, with other income being $2.1 million compared to $1.9 million. GROSS PROFIT: Gross profit (excluding other income) was $64.3 million or 37.4% compared with $53.2 million or 37.1%. For the nine months, gross margin was 38.1% versus 37.7%. OPERATING EXPENSES: Operating expenses increased 11% to $48.1 million, but the increase is well below the 19.9% sales increase. Management aggressively focuses on costs, and we do not think this discipline will change in the future. OPERATING INCOME: Operating income for the period was $17.7 million or 10.2% of sales compared with $9.5 million or 6.6% a year ago. For the nine months, operating income was $54.7 million versus $34.8 million. NET INCOME (LOSS): Net income from continuing operations was $111.0 million compared with $5.3 million. EPS from continuing operations was $0.88 versus $0.43. Discontinued operations added $1.09 this year versus $0.04 last year. For the nine months, net income from continuing operations was $33.7 million compared with $20.9 million. EPS from continuing operations was $2.72 versus $1.70. Discontinued operations added $1.32 this year versus $0.19 last year. FINANCIAL STRENGTH: Cash at the end of the quarter was $101.7 million, inclusive of the funds from the chemical division sale. MSA sells on a continuous basis an undivided interest in all eligible trade accounts receivable under a securitization agreement. There was $40.7 million in proceeds to MSA at September 30, DSOs were about 64 days, down from 74 days at the end of the second quarter. We do not have access to geographic dispersion of accounts receivable data, so the above calculation is a gross number for the company. We expect domestic DSOs are substantially below this number, and international (except perhaps Europe) is well above this number. Debt was $64 million, and shareholders equity was $341.3 million. Cash flow from continuing operations was about $24.0 million. Page3 Mine Safety Appliances Company (MSA) 11/6/03

4 OPERATING MODEL CHANGES: Revenue Est. Revenue Est. EPS Est. EPS Est. Old New Old New Q4 2003E $163.2 $172.3 $0.89 $ E $674.0 $683.0 $3.55 $3.62 Q1 2004E $175.1 $175.1 $0.93 $0.94 Q2 2004E $192.0 $192.0 $1.03 $1.04 Q $172.2 $187.7 $0.90 $0.94 Q $178.1 $188.0 $0.93 $ E $716.4 $742.8 $3.80 $3.90 RISKS THAT TARGET PRICE MAY NOT BE ACHIEVED Based on third quarter results, international revenue (Europe and Rest of World) amounted to about 37%. Foreign exchange gains in the second quarter amounted to $121K. Any factors affecting the ability of MSA to sell into these global markets, or factors creating dollar fluctuations can impact the operating results of MSA. While terrorism is a driving force behind the increased funding for first responders, such activities, should they occur, can create geo-political instability, which could impact MSA s results. It is incumbent on MSA to continue the timely and successful introduction of new products. R&D funds will continue to be needed to keep MSA s product line at the forefront for safety and effectiveness. Funds for first responders are an integral element in MSA s business strategy. U.S. budgets (and those from countries abroad) for first responders are expected to increase, but the timing of such spending is uncertain, and can fluctuate. The majority of MSA s sales are for products that it manufactures. Fluctuations in the cost and availability of key materials and components could impact MSA s operating performance. The ability of MSA to meet its sales and earnings forecasts can, and will, have a direct influence on its ability to repay debt. A failure to meet such expectations could impact MSA s ability to service or pay its debt. The foregoing list is not exhaustive. Other specific fundamental risks relating to MSA s operations can be found in the company s various 10K and 10Q filings. Companies referenced: Tyco Int l (TYC - $22.20 Not rated) Home Depot (HC - $37.10 Not rated) Analyst Certification I, Richard Ryan, certify that the views expressed in this research report accurately reflect my personal views about the subject company and its securities. I also certify that I have not been, am not, and will not receive direct or indirect compensation related to the specific recommendations expressed in this report. Page4 Mine Safety Appliances Company (MSA) 11/6/03

5 Mine Safety Appliances Co. Earnings Model Fiscal Year Ends - Dec. $s in 000s FY 2000 FY 2001 Q1 02 Q2 02 Q3 02 Q4 02 FY 2002 Q1 03 Q2 03 Q3 03 Q4 03E FY 2003 FY 2004 Net Sales $468,307 $509,736 $128,058 $141,862 $143,398 $151,108 $564,426 $160,391 $175,939 $171,927 $172,263 $680,520 $741,767 Other Income 2,444 2,776 (157) 2,312 (231) 347 2, , ,516 1,000 Total Sales $470,751 $512,512 $128,058 $144,174 $143,167 $151,455 $566,854 $160,487 $176,373 $173,513 $172,663 $683,036 $742,767 Cost of Product Sold 293, ,680 77,630 89,966 90,167 94, ,996 98, , , , , ,603 % of Rev. 62.4% 60.4% 60.6% 62.4% 63.0% 62.2% 62.1% 61.6% 61.3% 62.0% 61.7% 61.7% 62.0% Gross Profit on Product Sold 174, ,056 50,428 51,896 53,231 56, ,430 61,496 67,799 64,318 65, , ,164 % of Rev. 37.2% 39.2% 39.4% 36.6% 37.1% 37.6% 37.6% 38.3% 38.5% 37.4% 38.2% 38.1% 38.0% S, G & A 124, ,092 30,672 36,581 36,054 37, ,479 39,096 42,219 41,761 40, , ,224 % of Rev. 26.5% 25.4% 24.0% 25.4% 25.2% 24.5% 24.8% 24.4% 23.9% 24.1% 23.5% 24.0% 23.4% Depr. And Amort. 20,936 22,590 5,042 5,319 6,477 3,708 20,546 5,393 5,657 6,434 6,417 23,901 26,333 % of Rev. 4.4% 4.4% 3.9% 3.7% 4.5% 2.4% 3.6% 3.4% 3.2% 3.7% 3.7% 3.5% 3.6% Currency Exchange (gain) (444) 1, (1,075) 866 (505) (1 91 ) (1,150) (651) 0 0 (1,801) - % of Rev. -0.1% 0.2% 0.4% -0.7% 0.6% -0.3% 0.0% -0.7% -0.4% 0.0% 0.0% -0.3% 0.0% Total Operating Expenses 145, ,879 36,237 40,825 43,397 40, ,834 43,339 47,225 48,195 46, , ,557 % of Rev. 30.9% 30.0% 28.3% 28.3% 30.3% 26.7% 28.5% 27.0% 26.8% 27.8% 27.2% 27.3% 26.9% Operating Income 31,459 48,953 14,034 13,383 9,505 16,847 53,867 18,253 21,008 17,709 19,134 76,104 83,607 % of Rev. 6.7% 9.6% 11.0% 9.3% 6.6% 11.1% 9.5% 11.4% 11.9% 10.2% 11.1% 11.2% 11.3% Interest Expense 4,040 5,349 1,171 1, ,160 1,119 1, ,250 3,542 4,750 Pre-Tax Income 27,419 43,604 12,863 12,143 9,505 16,098 50,609 17,134 19,835 17,709 17,884 72,562 78,857 Taxes 8,531 17,753 5,432 5,182 4,182 1,796 16,592 6,635 7,643 6,725 6,796 27,799 29,966 % of Rev. 31.1% 40.7% 42.2% 42.7% 44.0% 11.2% 32.8% 38.7% 38.5% 38.0% 38.0% 38.3% 38.0% Net Income from Cont. Ops. 18,888 25,851 7,724 7,897 5,323 10,269 31,213 10,499 12,192 10,984 11,088 44,763 48,892 % of Rev. 4.0% 5.0% 6.0% 5.5% 3.7% 6.8% 5.5% 6.5% 6.9% 6.3% 6.4% 6.6% 6.6% Net Income from Discont. Ops. 4,351 5, , ,547 3,864 1,514 1,273 (102) 0 2,685 0 Gain on Sale of Disc. Ops. (net) , ,658 0 Net Income $23,239 $31,631 $7,984 $9,484 $5,793 $11,816 $35,077 $12,013 $13,465 $24,540 $11,088 $61,106 48,892 Diluted EPS - Disc. Ops Diluted EPS - Cont. Ops Reported EPS - Diluted $1.89 $2.61 $0.65 $0.77 $0.47 $0.96 $2.85 $0.98 $1.09 $1.97 $0.89 $4.95 $3.90 Shares Out - Diluted 12,321 12,136 12,260 12,317 12,379 12,361 12,289 12,208 12,231 12,482 12,500 12,355 12,550 EBITDA $52,395 $71,543 $19,076 $18,702 $15,982 $20,555 $74,413 $23,646 $26,665 $24,143 $25,550 $100,004 $109,940 EBITDA/Share $4.25 $5.90 $1.56 $1.52 $1.29 $1.66 $6.06 $1.94 $2.18 $1.93 $2.04 $8.09 $8.76 Page5 11/6/03

6 Feltl and Company Rating System: Feltl and Company utilizes a four tier rating system for potential total returns over the next 12 months, and a three tier system for risk assessment. Potential Total Return Assessment Strong Buy: The stock is expected to have total return potential of at least 30%. Catalysts exist to generate higher valuations, and positions should be initiated at current levels. Buy: The stock is expected to have total return potential of at least 15%. Near term catalysts may not exist and the common stock needs further time to develop. Investors requiring time to build positions may consider current levels attractive. Hold: The stock is expected to have total return potential of less than 15%. Fundamental events are not present to make it either a Buy or a Sell. The stock is an acceptable longer-term holding. Sell: Expect a negative total return. Current positions may be used as a source of funds. Related Risk Assessment Speculative: Business and financial risks are significantly greater than the market risk. The company has an inconsistent operating history and the share price may have significant volatility. Aggressive: Business and financial risks are higher than the market risk. The company has a history of revenue growth and/or operating profits. The share price may be more volatile than the general market. Market: Business and financial risks are in line with the general market. Disclosure Statement The information contained in this report is based on sources considered to be reliable, but not guaranteed, to be accurate or complete. Any opinions or estimates expressed herein reflect a judgment made of this date, and are subject to change without notice. This report has been prepared solely for informative purposes and is not a solicitation or an offer to buy or sell any security. The securities described may not be qualified for purchase in all jurisdictions. Because of individual requirements, advice regarding securities mentioned in this report should not be construed as suitable for all accounts. This report does not take into account the investment objectives, financial situation and needs of any particular client of Feltl and Company. Some securities mentioned herein relate to small speculative companies that may not be suitable for some accounts. Feltl and Company suggests that prior to acting on any of the recommendations herein, the recipient should consider whether such a recommendation is appropriate given their investment objectives and current financial circumstances. Past performance does not guarantee future results. Conflicts of Interest Investors should assume that Feltl and Company is seeking or will seek investment banking or other business from the companies in our research universe. From time to time, Feltl and Company, or its officers, directors or agents, or members of their families, may have a position in securities mentioned and may make purchases or sales of the same in the open market or otherwise, and may own options, rights or warrants to purchase the same. Feltl and Company may be a market maker and may act as principal or agent with respect to the sale or purchase of securities mentioned, and may have managed or co-managed a public offering of the securities mentioned within the last three years. Additional information is available upon request. Feltl & Company does make a market in the subject security at the date of publication of this report. As a market maker, Feltl & Co. could act as principal or agent with respect to the purchase or sale of those securities. As of the end of the month preceding the date of publication of this report, Feltl & Co. did not beneficially own 1% or more of any class of common equity securities of the subject company. Feltl & Co. has not been engaged for investment banking services with the subject company during the past twelve months and does not anticipate receiving compensation for such services in the next three months. The analyst or any member of his/her household does not hold a long or short position, options, warrants, rights or futures of this security in their personal account(s). The analyst has not received any compensation for any investment banking business with this company in the past twelve months and does not expect to receive any in the next three months. Page6

7 No director, officer or employee of Feltl & Co. serves as a director, officer or advisory board member to the subject company. Feltl & Co. has not served as a broker, either as agent or principal, buying back stock for the subject company s account as part the company s authorized stock buy-back program in the last twelve months. Feltl & Co. may possibly serve as the company s broker, either as agent or principal, as part of the company s authorized buy-back program in the next three months. There is not any actual material conflict of interest that either the analyst or Feltl and Company is aware of. Feltl and Company provided investment banking services for 3% of the research covered companies over the last twelve months, of which one was rated Buy/Strong Buy and none were rated Hold or Sell. Date Nature of Report Rating Price Target 8/20/03 Coverage Initiated Buy $ /5/2003 Q3 Results Buy $ /20/02 Buy - $65.00 Target 11/6/03 Buy - $75.00 Target Chart: Reuters Ratings Distribution for Feltl & Co. 11/06/03 Hold 40% Sell 0% SB/Buy 60% Page7

8 EQUITY CAPITAL MARKETS DIRECTORY RESEARCH DEPARTMENT Ernest W. Andberg, CFA Dennis E. Nielsen, CFA Richard A. Ryan (612) Joseph P. Sullivan, CFA (612) INSTITUTIONAL SALES: (866) Thomas Pierce Senior Vice President Institutional Sales (612) Mark Hagen (612) Paul M. Manley Ryan Quade (612) TRADING: (866) Jo Pihl Senior Vice President (612) James G. Fredericks Vice President Manager, Equity Trading (612) Joseph G. Fredericks (612) Daniel L. Hennen (612) William W. Koop (612) Deborah L. Zieman Institutional Sales Trading (612) /03/ SOUTH SIXTH STREET SUITE 2600 MINNEAPOLIS, MINNESOTA (612) (866) MEMBER SIPC & NASD

(DAKT - - $16.12) 26, 2003 DAKT

(DAKT - - $16.12) 26, 2003 DAKT Dennis Nielsen denielsen@feltl.com (612) 492-8806 Consumer Products - Durables August 26, 2003 Financial Summary Rev (mil) 2002 2003A 2004E July $40.2 $44.1 $48.9A Oct $41.6 $48.1 $54.8E Jan $30.9 $38.2

More information

MINE SAFETY APPLIANCES CO. (MSA - $47.98) Initiating Coverage BUY Aggressive

MINE SAFETY APPLIANCES CO. (MSA - $47.98) Initiating Coverage BUY Aggressive Richard A. Ryan raryan@feltl.com (612) 492-8841 Safety Equipment Manufacturer August 20, 2003 Financial Summary Rev 2002 2003E 2004E (mil) March $128.1 $160.4A $175.1E June $141.9 $175.9A $192.0E Sept.

More information

Stellent, Inc. (STEL - $8.59)

Stellent, Inc. (STEL - $8.59) Richard A. Ryan raryan@feltl.com (612) 492-8841 Enterprise Software August 7, 2006 Financial Summary Rev(mil) 2005 2006 2007E Jun $22.3 $28.6 $32.3A Sep $28.0 $30.1 $33.4E Dec $27.7 $31.7 $34.8E Mar $28.5

More information

Micro Component Technology (MCTI - $0.43) Q4 Results Below Estimates Key Points:

Micro Component Technology (MCTI - $0.43) Q4 Results Below Estimates Key Points: Richard A. Ryan raryan@feltl.com (612) 492-8841 Semiconductor Cap. Equipment February 17, 2005 Financial Summary Rev(mil) 2003 2004 2005E Mar $ 2.2 $ 4.3 $2.3E Jun $ 2.3 $ 4.2 $2.8E Sep $ 2.9 $ 3.9 $3.5E

More information

Astronics Corporation (ATRO - $16.35) Coverage terminated.

Astronics Corporation (ATRO - $16.35) Coverage terminated. Richard A. Ryan raryan@feltl.com (612) 492-8841 Aerospace Supplier May 12, 2008 Financial Summary Rev(mil) 2007 2008E 2009 Mar $ 42.9 $ 41.1 - Jun $ 41.4 - Sep $ 37.7 - Dec $ 36.3 - FY $158.2 P/Sales 0.8x

More information

Compex Technologies, Inc. (CMPX - $4.89)

Compex Technologies, Inc. (CMPX - $4.89) Ernest W. Andberg, CFA ewandberg@feltl.com (612) 492-8836 Medical Devices February 10, 2005 Financial Summary Rev(mil) 2004 2005E 2006E Sep $19.2 $21.7A $ Dec $22.5 $25.2A $ Mar $21.7 $24.6 $ Jun $22.7

More information

Domino s Pizza, Inc.

Domino s Pizza, Inc. Feltl and Company Research Department 225 South Sixth Street, Suite 4200 Minneapolis, MN 55402 1.866.655.3431 Mark E. Smith mesmith@feltl.com 612.492.8806 Domino s Pizza, Inc. Company Description: Domino

More information

Hibbett Sports Inc. (HIBB - $50.89) BUY

Hibbett Sports Inc. (HIBB - $50.89) BUY Hibbett Sports Inc. Company Description: Hibbett Sports Inc. operates 848 sporting goods stores in the United States with most stores located in the Southeast. Hibbett is a full service sporting goods

More information

Digi International, Inc.

Digi International, Inc. Feltl and Company Research Department 225 South Sixth Street, Suite 4200 Minneapolis, MN 55402 1.866.655.3431 Jay M. Meier jmmeier@feltl.com 612.492.8847 Digi International, Inc. Company Description: Digi

More information

American Vanguard (AVD - $25.01) STRONG BUY

American Vanguard (AVD - $25.01) STRONG BUY American Vanguard American Vanguard is a small but rapidly growing manufacturer and marketer of crop protection products like insecticides, herbicides, and fungicides for use by a variety of farmers. In

More information

Vascular Solutions, Inc.

Vascular Solutions, Inc. Vascular Solutions, Inc. Vascular Solutions is a medical device company focused on developing products for the interventional radiology and cardiology markets. Current product offerings include the Duett

More information

MEDNAX, Inc. Better than expected results inline with our propriety research; raising estimates

MEDNAX, Inc. Better than expected results inline with our propriety research; raising estimates MEDNAX, Inc. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN 55402 1.866.655.3431 Matt J. Weight mjweight@feltl.com 612.492.8812 Healthcare Services August 1,

More information

MSA Reports Higher Sales on Strength in Industrial Markets

MSA Reports Higher Sales on Strength in Industrial Markets FROM: MSA (Mine Safety Appliances Company) Ticker: MSA (NYSE) Contact: Mark Deasy (412) 967-3357 FOR IMMEDIATE RELEASE MSA Reports Higher Sales on Strength in Industrial Markets PITTSBURGH, July 28, 2010

More information

MSA Announces Fourth Quarter and Full Year Results

MSA Announces Fourth Quarter and Full Year Results FROM: MSA (Mine Safety Appliances Company) Ticker: MSA (NYSE) Contact: Mark Deasy (412) 967-3357 FOR IMMEDIATE RELEASE MSA Announces Fourth Quarter and Full Year Results PITTSBURGH, February 26, 2010 MSA

More information

Jefferies Global Industrials Conference

Jefferies Global Industrials Conference Because every life has a purpose Jefferies Global Industrials Conference MSA Safety Kenneth Krause, Executive Director of Global Finance and Assistant Treasurer Safe Harbor Except for historical information,

More information

Vascular Solutions, Inc. (VASC - $9.21)

Vascular Solutions, Inc. (VASC - $9.21) Medical Devices March 23, 2005 Financial Summary Rev(mil) 2004 2005E 2006E Mar $4.4 $7.0E $ Jun $5.2 $7.6E $ Sep $5.9 $8.6E $ Dec $6.7 $9.9E $ FY $22.3 $33.0E $45.0E P/Sales 5.9x 4.0x 2.9x EPS 2004 2005E

More information

Calgon Carbon Corporation Rating: Hold

Calgon Carbon Corporation Rating: Hold WATER COMPANIES Christopher Bamman 212-218-3989 cbamman@morganjoseph.com Richard S. Paget, CFA 212-218-3894 rpaget@morganjoseph.com Company Update / Estimates Change February 25, 2008 Key Metrics CCC -

More information

DexCom, Inc. (DXCM - $15.73) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

DexCom, Inc. (DXCM - $15.73) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN DexCom, Inc. Company Description: DexCom is a real-time diagnostics medical device company focused on the continuous glucose monitoring (CGM) market for both diabetics and critical care patients. The company

More information

Note Important Disclosures on Pages 6 and 7. Note Analyst Certification on Page 6.

Note Important Disclosures on Pages 6 and 7. Note Analyst Certification on Page 6. COMPANY UPDATE / ESTIMATE CHANGES Key Metrics IRET - NASDAQ (as of 12/11/2017) $5.88 Price Target N/A 52-Week Range $5.60 - $7.28 Shares & Units Outstanding (mm) 135 Market Cap. ($mm) $794 3-Mo. Average

More information

MSA Announces First Quarter Results Higher product margins and lower cost structure drive 14 percent growth in quarterly net income

MSA Announces First Quarter Results Higher product margins and lower cost structure drive 14 percent growth in quarterly net income FOR IMMEDIATE RELEASE FROM: MSA Safety Incorporated Ticker: MSA (NYSE) Media Relations Contact: Mark Deasy (724) 741-8570 Investor Relations Contact: Kenneth Krause (724) 741-8534 MSA Announces First Quarter

More information

DexCom, Inc. (DXCM - $14.30) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

DexCom, Inc. (DXCM - $14.30) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN DexCom, Inc. Company Description: DexCom is a real-time diagnostics medical device company focused on the continuous glucose monitoring (CGM) market for both diabetics and critical care patients. The company

More information

Synovis Life Technologies, Inc. (SYNO - $17.89) HOLD. Dennis E. Nielsen, CFA (612)

Synovis Life Technologies, Inc. (SYNO - $17.89) HOLD. Dennis E. Nielsen, CFA (612) Dennis E. Nielsen, CFA denielsen@feltl.com (612) 492-8806 Medical Devices June 2, 2003 Financial Summary Rev (mil) 2002 2003E 2004E Jan $8.0 $12.5A Apr $9.5 $15.3A Jul $10.7 $14.0E Oct $11.8 $14.5E FY

More information

Quarterly Highlights Revenue was $296 million, increasing 6 percent from a year ago on a reported basis and 5 percent on a constant currency basis.

Quarterly Highlights Revenue was $296 million, increasing 6 percent from a year ago on a reported basis and 5 percent on a constant currency basis. FOR IMMEDIATE RELEASE FROM: Ticker: MSA (NYSE) Media Relations Contact: Mark Deasy (724) 741-8570 Investor Relations Contact: Kenneth Krause (724) 741-8534 MSA Announces Third Quarter Results Strategic

More information

Reported revenue was $1.15 billion, increasing 2 percent from a year ago on a reported basis and 4 percent on a constant currency basis.

Reported revenue was $1.15 billion, increasing 2 percent from a year ago on a reported basis and 4 percent on a constant currency basis. FOR IMMEDIATE RELEASE FROM: MSA Safety Incorporated Ticker: MSA (NYSE) Media Relations Contact: Mark Deasy (724) 741-8570 Investor Relations Contact: Kenneth Krause (724) 741-8534 MSA Announces Full-Year

More information

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5.

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5. COMPANY UPDATE / ESTIMATE CHANGE / PRICE TARGET CHANGE Key Metrics FUN - NYSE (as of 9/11/17) $64.67 Two Year Price Target $77.00 52-Week Range $56.23 - $72.56 Shares Outstanding (mil) (basic) 56.1 Market

More information

Reported revenue was $346 million, increasing 17 percent from a year ago on a reported basis and 14 percent on a constant currency basis.

Reported revenue was $346 million, increasing 17 percent from a year ago on a reported basis and 14 percent on a constant currency basis. FOR IMMEDIATE RELEASE FROM: MSA Safety Incorporated Ticker: MSA (NYSE) Media Relations Contact: Mark Deasy (724) 741-8570 Investor Relations Contact: Elyse Lorenzato (724) 741-8525 MSA Announces Fourth

More information

INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Pareteum (NYSE American/TEUM) BUY

More information

Note Important Disclosures on Pages 6-7 Note Analyst Certification on Page 6.

Note Important Disclosures on Pages 6-7 Note Analyst Certification on Page 6. COMPANY UPDATE / ESTIMATE CHANGE Key Metrics FUN - NYSE (as of 11/2/17) $65.42 Two Year Price Target $77.00 52-Week Range $58.05 - $72.56 Shares Outstanding (mil) (basic) 56.1 Market Cap. ($mil) $3,669

More information

ResMed, Inc. (RMD - $29.84) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

ResMed, Inc. (RMD - $29.84) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN ResMed, Inc. Company Description: ResMed develops, manufactures and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing (SDB) and other respiratory disorders.

More information

FOR IMMEDIATE RELEASE

FOR IMMEDIATE RELEASE FOR IMMEDIATE RELEASE FROM: MSA Safety Incorporated Ticker: MSA (NYSE) Media Relations Contact: Mark Deasy (724) 741-8570 Investor Relations Contact: Elyse Lorenzato (724) 741-8525 MSA Announces Second

More information

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5 COMPANY UPDATE ESTIMATE CHANGE Key Metrics FELE - NASDAQ - as of 2/20/18 $39.85 Price Target -- 52-Week Range $36.00 - $47.20 Shares Outstanding (mm) 46.6 Market Cap. ($mm) $1,856.9 1-Mo. Average Daily

More information

DexCom, Inc. Tickled pink Q3 EPS less red than our estimate and new G4 color choice

DexCom, Inc. Tickled pink Q3 EPS less red than our estimate and new G4 color choice DexCom, Inc. Company Description: DexCom is a real-time diagnostics medical device company focused on the continuous glucose monitoring (CGM) market for both diabetics and critical care patients. The company

More information

ResMed, Inc. (RMD - $44.37) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

ResMed, Inc. (RMD - $44.37) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN ResMed, Inc. Company Description: ResMed develops, manufactures and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing (SDB) and other respiratory disorders.

More information

DaVita Inc. (DVA - $119.21) BUY. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

DaVita Inc. (DVA - $119.21) BUY. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN DaVita Inc. Company Description: DaVita Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. Feltl

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Dec 29, 2011 Page 1 OF 5 United Technologies is an aerospace-industrial conglomerate whose portfolio includes Climate Control & Security (which now combines UTC Fire Security with Carrier),

More information

Oramed Pharmaceuticals Inc. (ORMP $7.21*)

Oramed Pharmaceuticals Inc. (ORMP $7.21*) Oramed Pharmaceuticals Inc. (ORMP $7.21*) Healthcare: Specialty Pharmaceuticals Buy; $20.00 PT; $104.2M Market Cap Company Update Tuesday, April 17, 2018 Revenue/EPS for 2Q18 in Line/Beat Estimates; Time

More information

The Ensign Group, Inc. (NASDAQ:ENSG)

The Ensign Group, Inc. (NASDAQ:ENSG) The Ensign Group, Inc. (NASDAQ:ENSG) ENSG - Thesis Remains Intact; Reiterate MO MARKET OUTPERFORM COMPANY UPDATE Post Acute Care - Facilities February 14, 2013 Kevin Campbell, CFA, Managing Director kcampbell@avondalepartnersllc.com

More information

Aveda Transportation and Energy Services Inc. (AVE-V)

Aveda Transportation and Energy Services Inc. (AVE-V) Aveda Transportation and Energy Services Inc. (AVE-V) Strong Q3 Results Driven by Impressive US Growth November 5, 2013 Michael Mills, CFA (902) 425-8897 mmills@beaconsecurities.ca Aveda reported inline

More information

Lotte Hi-Mart ( KS)

Lotte Hi-Mart ( KS) (071840 KS) Margins to improve in 2H Retail Results Comment May 12, 2014 (Maintain) Buy Target Price (12M, W) 89,000 Share Price (5/9/14, W) 72,300 Expected Return 23% OP (, Wbn) 187 Consensus OP (, Wbn)

More information

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE 9 27 31 A S D 10 2016 4 S N D 14 18 2017 26 2 2018 8 16 22 29 F 5 12 20 26 LIVEXLIVE ED IA O RD (5.81000, 5.974,5.67000,5.77000,+0.01000) Relative Strength Index (45.7825) 5 12 19 26 2 A 9 16 23 30 7 14

More information

Note Important Disclosures on Pages 5-6 Note Analyst Certifications on Page 5

Note Important Disclosures on Pages 5-6 Note Analyst Certifications on Page 5 COMPANY UPDATE / ESTIMATE CHANGE Key Metrics WGL - NYSE - as of 2/7/18 $85.41 Price Target -- 52-Week Range $81.59 - $86.89 Shares Outstanding (mm) 51.4 Market Cap. ($mm) $4,386.0 1-Mo. Average Daily Volume

More information

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin.

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin. DOL (T) $110.88 Stock Rating: Outperform (Unchanged) Target: $122.00 (Was $113.00) Risk Rating: Below Average (Unchanged) Est. Total Return: 10.4% Stock Data: 52-week High-Low (Canada) Bloomberg $104.94

More information

Electronic Arts Inc. EA NASDAQ Neutral-2 Good 2Q Results; Neutral Rating Based on Stock Valuation

Electronic Arts Inc. EA NASDAQ Neutral-2 Good 2Q Results; Neutral Rating Based on Stock Valuation COMPANY UPDATE / ESTIMATE CHANGE Key Metrics EA - NASDAQ (as of 10/31/17) $119.60 Two Year Price Target N/A 52-Week Range $73.74 - $122.79 Shares Outstanding (mil) 309 Market Cap. ($mil) $36,956 3-Mo.

More information

China Renewable Energy Investment Ltd (987_HK)

China Renewable Energy Investment Ltd (987_HK) Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9

More information

Q Earnings. July 26, 2017

Q Earnings. July 26, 2017 Q3 2017 Earnings July 26, 2017 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S. Private

More information

Stryker Corp. Post-4Q15 Thoughts

Stryker Corp. Post-4Q15 Thoughts EQUITY RESEARCH QUARTERLY UPDATE January 27, 2016 Stock Rating: PERFORM 12-18 mo. Price Target $104.00 SYK - NYSE $96.02 3-5 Yr. EPS Gr. Rate 9% 52-Wk Range $105.34-$86.68 Shares Outstanding 378.4M Float

More information

Note Important Disclosures on Pages 6-7. Note Analyst Certification on Page 6.

Note Important Disclosures on Pages 6-7. Note Analyst Certification on Page 6. COMPANY UPDATE / ESTIMATE CHANGES Key Metrics DDR - NYSE (as of 2/15/2018) $7.40 Price Target NA 52-Week Range $6.77 - $14.89 Shares & Units Outstanding (mm) (as of 12/2017) 369 Market Cap. ($mm) 2730.6

More information

Steve Bachelder Chief Operating Officer September 2016

Steve Bachelder Chief Operating Officer September 2016 NASDAQ: LAKE Steve Bachelder Chief Operating Officer September 2016 Emerging Markets Exposure Western Markets Expertise Safe Harbor Statement With the exception of historical information, the statements

More information

Activision Blizzard, Inc. ATVI NASDAQ Underperform-2

Activision Blizzard, Inc. ATVI NASDAQ Underperform-2 COMPANY UPDATE / ESTIMATE CHANGE Key Metrics ATVI - NASDAQ (as of 8/4/17) $62.01 Price Target N/A 52-Week Range $35.12 - $64.06 Shares Outstanding (mil) (basic) 754 Market Cap. ($mil) $46,756 3-Mo. Average

More information

SodaStream Follow-Up: 1Q Results Better Than Expected; Guidance Raised; Wal-Mart!!!

SodaStream Follow-Up: 1Q Results Better Than Expected; Guidance Raised; Wal-Mart!!! EQUITY RESEARCH COMPANY UPDATE May 9, 2012 Stock Rating: OUTPERFORM 12-18 mo. Price Target $55.00 SODA - NASDAQ $36.90 3-5 Yr. EPS Gr. Rate 30% 52-Wk Range $79.72-$27.60 Shares Outstanding 19.9M Float

More information

BTO: Q2/15 Earnings Preview

BTO: Q2/15 Earnings Preview B2Gold Corp. (BTO-T: C$1.69), (BTG-N: US$1.31) August 13, 2015 BUY, High Risk Dundee target: C$2.75 BTO: Q2/15 Earnings Preview Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com

More information

Christopher J. Ryan Chief Executive Officer 29 th Annual ROTH Conference -- March 2017

Christopher J. Ryan Chief Executive Officer 29 th Annual ROTH Conference -- March 2017 NASDAQ: LAKE Christopher J. Ryan Chief Executive Officer 29 th Annual ROTH Conference -- March 2017 Emerging Markets Exposure Western Markets Expertise Safe Harbor Statement With the exception of historical

More information

Q Financial Results. July 22, 2010

Q Financial Results. July 22, 2010 Q2 2010 Financial Results July 22, 2010 Q2 2010 Non-GAAP Results Q2 10 Q2 09 Y/Y % growth Q1 10 Billings (1) $90M $69M 31% $79M Revenue $76M $61M 24% $70M Non-GAAP Gross Margin (%) (2) 74% 74% -- 73% Non-GAAP

More information

SodaStream Follow-Up: Very Strong 4Q Results Reflect Broad-Based Growth; Estimates Raised

SodaStream Follow-Up: Very Strong 4Q Results Reflect Broad-Based Growth; Estimates Raised EQUITY RESEARCH COMPANY UPDATE March 1, 2011 Stock Rating: OUTPERFORM 12-18 mo. Price Target $48.00 SODA - NASDAQ $39.68 3-5 Yr. EPS Gr. Rate 30% 52-Wk Range $46.88-$20.00 Shares Outstanding 19.2M Float

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 17, 2018 Page 1 OF 5 Citigroup is one of world's largest banks, with global consumer banking, corporate banking, and investment banking operations. Of the largest U.S. banks, Citigroup

More information

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5 COMPANY UPDATE / ESTIMATE CHANGE Key Metrics COP - NYSE - as of 7/27/17 $44.66 Price Target $65.00 52-Week Range $38.80 - $53.17 Shares Outstanding (mm) 1248.7 Market Cap. ($mm) 1-Mo. Average Daily Volume

More information

Morgan Stanley Reports Fourth Quarter and Full Year 2017

Morgan Stanley Reports Fourth Quarter and Full Year 2017 Subsequent to the release of Morgan Stanley s fourth quarter earnings on January 18, 2018, the Firm s results have been updated to reflect the latest financial figures reported in the Firm s Annual Report

More information

Dollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin.

Dollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin. DOL (T) $97.04 Stock Rating: Outperform (Unchanged) Target: $105.00 (Was $104.00) Risk Rating: Average (Unchanged) Est. Total Return: 8.6% Stock Data: 52-week High-Low (Canada) Bloomberg $98.94 - $66.32

More information

Note Important Disclosures on Pages 7-8. Note Analyst Certification on Page 7. COMPANY UPDATE / ESTIMATE CHANGE

Note Important Disclosures on Pages 7-8. Note Analyst Certification on Page 7. COMPANY UPDATE / ESTIMATE CHANGE COMPANY UPDATE / ESTIMATE CHANGE Key Metrics GME - NYSE (as of 11/24/17) $17.42 Price Target N/A 52-Week Range $15.85 - $26.84 Shares Outstanding (mil) 101.4 Market Cap. ($mil) $1,766 3-Mo. Average Daily

More information

CalAmp Corp. CAMP - $ NASDAQ Buy

CalAmp Corp. CAMP - $ NASDAQ Buy Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH June 28, 2018 Technology: Communications, Wireless & IoT CalAmp Corp. CAMP

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

Q Earnings. July 25, 2018

Q Earnings. July 25, 2018 Q3 2018 Earnings July 25, 2018 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S. Private

More information

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook

More information

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5

Note Important Disclosures on Pages 5-6 Note Analyst Certification on Page 5 COMPANY UPDATE / TARGET CHANGE ESTIMATE CHANGE Key Metrics SR - NYSE - as of 8/1/17 $73.40 Price Target $90.00 52-Week Range $59.54 - $73.70 Shares Outstanding (mm) 48.3 Market Cap. ($mm) $3,542.2 1-Mo.

More information

Trailing PE Forward PE Buy 5 Analysts. 1-Year Return: 16.8% 5-Year Return: 204.7%

Trailing PE Forward PE Buy 5 Analysts. 1-Year Return: 16.8% 5-Year Return: 204.7% AIRS OF AMERICA CORP (-T) Last Close 14.20 (CAD) Avg Daily Vol 28,574 52-Week High 14.35 Trailing PE 21.6 Annual Div 0.28 ROE 11.1% LTG Forecast -- 1-Mo 11.9% 2018 April 26 TORONTO Exchange Market Cap

More information

Q Earnings. November 1, 2017

Q Earnings. November 1, 2017 Q4 2017 Earnings November 1, 2017 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.

More information

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74 Equity Research Winner of next 5 years, BUY 2017 result: slow growth, but high profitability Revenue slightly improved by 8.5% YoY to HKD 118.5 bn. Thanks to GPM growing by 6.5 pts to 40%, gross profit

More information

Note Important Disclosures on Pages 6 and 7. Note Analyst Certification on Page 6.

Note Important Disclosures on Pages 6 and 7. Note Analyst Certification on Page 6. COMPANY UPDATE / ESTIMATE CHANGES Key Metrics WRI - NYSE (as of 2/21/2018) $27.15 Price Target N/A 52-Week Range $25.96 - $35.94 Shares Outstanding (mm) 129 Market Cap. ($mm) $3,502 3-Mo. Average Daily

More information

LifeVantage Corp. NasdaqCM: LFVN

LifeVantage Corp. NasdaqCM: LFVN LifeVantage Corp. NasdaqCM: LFVN New Products and Valuation Outweigh issues in Japan, reiterate Strong Buy LifeVantage Corp (LFVN) focuses on selling healthy living products through direct selling. They

More information

Equity Research. Beacon Roofing Supply, Inc. (BECN-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation

Equity Research. Beacon Roofing Supply, Inc. (BECN-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation Equity Research July 7, 2006 Mario Ricchio www.zacks.com 155 North Wacker Drive Chicago, IL 60606 Beacon Roofing Supply, Inc. (BECN-NSDQ) Current Recommendation Hold Prior Recommendation Buy Date of Last

More information

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time April 27, 2018 Company Sponsored Research Morning Meeting Note Lower Price Target; Lower Earnings Estimates Socket Mobile, Inc. (SCKT) Equity Research Lower Price Target To $4 (From $6); Near-Term Trends

More information

Daewoong Pharmaceutical (069620)

Daewoong Pharmaceutical (069620) Earnings Review July 31, 2014 12M rating BUY (Maintain) 12M TP W85,000 from W85,000 Up/downside +44% Stock Data KOSPI (Jul 30, pt) 2,083 Stock price (Jul 30, KRW) 58,900 Market cap (USD mn) 666 Shares

More information

Q Earnings. April 25, 2018

Q Earnings. April 25, 2018 Q2 2018 Earnings April 25, 2018 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.

More information

Alphabet Inc. GOOGL - NASDAQ Neutral -1

Alphabet Inc. GOOGL - NASDAQ Neutral -1 COMPANY UPDATE / TARGET CHANGE ESTIMATE CHANGE Key Metrics GOOGL - NASDAQ - as of 5/1/17 $932.82 Price Target $1,000.00 52-Week Range $672.66 - $935.82 Diluted Shares Outstanding (mil) 702.0 Market Cap.

More information

Baird s 2011 Business Solutions Conference

Baird s 2011 Business Solutions Conference Baird s 2011 Business Solutions Conference Henrik Slipsager President and Chief Executive Officer David L. Farwell Senior Vice President Safe Harbor Our presentation today contains predictions, estimates

More information

ALPHA SELECT LIST CAS Medical Systems, Inc.

ALPHA SELECT LIST CAS Medical Systems, Inc. A Matt G. Hewitt Senior Research Analyst 612-334-6314 matthew.hewitt@craig-hallum.com Lucas Baranowski Research Analyst 612-334-8224 lucas.baranowski@craig-hallum.com Charlie Eidson, CPA Research Analyst

More information

Q Earnings. April 20, 2016

Q Earnings. April 20, 2016 Q2 2016 Earnings April 20, 2016 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.

More information

CEMEX Cemex Increases its Offer for Rinker by 22%

CEMEX Cemex Increases its Offer for Rinker by 22% Latin American Equity Research Mexico City, April 10, 2007 Flashnote Mexico Cement & Construction CEMEX Cemex Increases its Offer for Rinker by 22% Gonzalo Fernandez* BUY Vivian Salomón* Mexico: Banco

More information

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Sonoma Pharmaceuticals (Nasdaq/SNOA)

More information

Market Maps. April 2016 Bob Dickey, Technical Analyst. RBC Capital Markets, LLC / Portfolio Advisory Group U.S. Equities.

Market Maps. April 2016 Bob Dickey, Technical Analyst. RBC Capital Markets, LLC / Portfolio Advisory Group U.S. Equities. RBC Capital Markets, LLC / Portfolio Advisory Group U.S. Equities Image Area Market Maps April 2016 Bob Dickey, Technical Analyst For Important Disclosures, see slides 12 13 Priced as of March 30, 2016,

More information

Kona Grill, Inc. (KONA - $11.28) Initiating Coverage Growth

Kona Grill, Inc. (KONA - $11.28) Initiating Coverage Growth Mark W. Moeller mwmoeller@feltl.com (612) 492-8849 Upscale Casual Restaurants September 30, 2005 Financial Summary Rev(mil) 2004A 2005E 2006E Mar $5.3 $8.0A $10.3E Jun $5.6 $8.9A $11.5E Sep $6.6 $9.0E

More information

Electronic Arts Inc. EA NASDAQ Neutral-2 Fiscal 3Q Results Don t Tell the Story of Bright Future, Long-term Growth Prospects

Electronic Arts Inc. EA NASDAQ Neutral-2 Fiscal 3Q Results Don t Tell the Story of Bright Future, Long-term Growth Prospects COMPANY UPDATE / ESTIMATE CHANGE Key Metrics EA - NASDAQ (as of 1/30/18) $118.70 Current intra-day price (1/31/18) $127.81 Two Year Price Target N/A 52-Week Range $80.40 - $122.79 Shares Outstanding (mil)

More information

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Biofrontera (Nasdaq/BFRA) BUY

More information

D A I L Y R E S E A R C H C A L L P A C K

D A I L Y R E S E A R C H C A L L P A C K Sales & Research (212) 425-7500 www.argusresearch.com February 12, 2018 D A I L Y R E S E A R C H C A L L P A C K Changes in Argus s Target EPS New Prev COST Costco Wholesale Corp $200.00 $188.00 HCA HCA

More information

Vontobel Morning Note

Vontobel Morning Note Vontobel Morning Note 05-09-12 Contact your sales desk: Zurich : +41 58 283 50 51 London: +44 207 255 83 00 Cologne: +49 221 20 30 00 New York: +1 212 792 58 20 Summary What's new? - RICHEMONT (Buy, 70.0):

More information

Banks: Regional June 22, 2007

Banks: Regional June 22, 2007 Equity Research Company Update Estimates Change Price Target Change Manuel Ramirez, CFA 415-591-5072 mramirez@kbw.com Julianna Balicka 415-591-5078 jbalicka@kbw.com Market Price: $24.68 Target Price: $32.00

More information

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Acasti Pharma (Nasdaq/ACST) BUY

More information

Q Earnings. October 31, 2018

Q Earnings. October 31, 2018 Q4 2018 Earnings October 31, 2018 Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning

More information

Q Earnings. October 28, 2015

Q Earnings. October 28, 2015 Q4 2015 Earnings October 28, 2015 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.

More information

JK Lakshmi Cement. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research Expansions on schedule; lower costs to aid margins June 28, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price Rs385 Target

More information

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90 EARNINGS REVIEW 4Q17 Turkey Aviation 22 February 2018 TAV Airports Bottom-line below consensus We reduce our recommendation to Hold, while keeping our target price unchanged at TRY22.90/shr. We believe

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 12, 2018 Page 1 OF 5 JPMorgan Chase is one of world's largest diversified banking firms. The company operates a leading global corporate and investment bank and is the second-largest

More information

Q Earnings. July 20, 2016

Q Earnings. July 20, 2016 Q3 2016 Earnings July 20, 2016 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S. Private

More information

Note Important Disclosures on Pages 7 and 8. Note Analyst Certification on Page 7.

Note Important Disclosures on Pages 7 and 8. Note Analyst Certification on Page 7. COMPANY UPDATE / ESTIMATE CHANGE Key Metrics CBL - NYSE (as of 2/9/2018) $4.20 Price Target NA 52-Week Range Shares & Units Outstanding (mm) $4.00 - $10.93 199 Market Cap. ($mm) $836 3-Mo. Average Daily

More information

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015 RESULTS REVIEW 4QFY15 29 APR 2015 Marico Kaya INDUSTRY FMCG CMP (as on 28 Apr 2015) Rs 1,635 Target Price Rs 1,823 Nifty 8,240 Sensex 27,226 KEY STOCK DATA Bloomberg MAKA IN No. of Shares (mn) 13 MCap

More information

Q Earnings. April 26, 2017

Q Earnings. April 26, 2017 Q2 2017 Earnings April 26, 2017 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.

More information

Note Important Disclosures on Pages 5-6. Note Analyst Certification on Page 5.

Note Important Disclosures on Pages 5-6. Note Analyst Certification on Page 5. COMPANY UPDATE / ESTIMATE CHANGE Key Metrics CHDN - NASDAQ (as of 4/26/18) $274.85 Price Target N/A 52-Week Range $162.25 - $285.70 Shares Outstanding (mm) (basic) 14.4 Market Cap. ($mm) $3,958 3-Mo. Average

More information

PT Bukit Asam Tbk. Margin Expansion. BUY (TP: IDR 13,250) 23 October 2017

PT Bukit Asam Tbk. Margin Expansion. BUY (TP: IDR 13,250) 23 October 2017 PT Bukit Asam Tbk. Margin Expansion BUY (TP: IDR 13,250) 23 October 2017 High production number, but lower sales volume. PTBA posted strong production output in 3Q17 at 7.48 mn tons (+40.3% YoY, +51.4%

More information

WH Group (288 HK) 3Q17 growth continued to pick up Nov 20, 2017

WH Group (288 HK) 3Q17 growth continued to pick up Nov 20, 2017 WH Group (288 HK) 3Q17 growth continued to pick up 3Q17 growth momentum picked up and OPM continued to improved; NPM was lower than that of previous quarters Geographical segments saw varying performance

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jul 23, 2015 Page 1 OF 5 Boeing manufactures commercial jetliners and military aircraft as well as rotorcraft, electronic and defense systems, missiles, satellites, launch vehicles, and

More information